Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza) | |
Zhang, H; Yu, C; Jia, JY; Leung, SWS; Siow, YL; Man, RYK; Zhu, DY | |
刊名 | ACTA PHARMACOLOGICA SINICA |
2002-12 | |
卷号 | 23期号:12页码:1163-1168 |
关键词 | Salvia miltiorrhiza magnesium tanshinoate B (MTB) high pressure liquid chromatography |
ISSN号 | 1671-4083 |
文献子类 | Article |
英文摘要 | AIM: To detect the contents of four active components of Salvia miltiorrhiza in various commercially available danshen crude drugs and preparations. METHODS: Commercially available danshen crude drugs from different sources, as well as danshen pills and intravenous injection preparations containing danshen alone or in combination with other herbs were collected. The composition of these danshen samples was analyzed using HPLC. Specifically, the amounts of magnesium tanshinoate B (MTB), danshensu, isotanshinone IIA, and cryptotanshinone were determined. In some of these samples, the content of MTB was further confirmed by liquid chromatography-tandem mass spectrometer (LC-MS)/MS method. RESULTS: There were great variations in the amount of the four active ingredients in the commercially available danshen crude drugs and drug preparations in this study. The amount of MTB was the highest among the four components measured in the crude drugs. However, the amounts of MTB in all danshen preparations were much lower than those in crude drugs. The 2 lipophilic components, isotanshinone II, and cryptotanshinone, were very low or not detectable in both injection and oral preparations. CONCLUSION: MTB can be used to standardize the various forms of danshen crude drugs and drug preparations from different sources. In view of the variation in the amounts of MTB and other components, improvement in the production methods of danshen preparations is essential to ensure consistent amount of its active ingredients and reproducible pharmacological actions. |
WOS关键词 | MAGNESIUM LITHOSPERMATE-B ; RENAL RESPONSES ; INHIBITION ; RADIX ; RATS ; CONFIRMATION ; RELEASE ; CELLS |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
CSCD记录号 | CSCD:1492419 |
出版者 | ACTA PHARMACOLOGICA SINICA |
WOS记录号 | WOS:000179779100016 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/274300] |
专题 | 新药研究国家重点实验室 中科院受体结构与功能重点实验室 |
通讯作者 | Man, RYK |
作者单位 | 1.Univ Hong Kong, Fac Med, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China 2.Shanghai Xu Hui Dist Cent Hosp, Shanghai 200031, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, H,Yu, C,Jia, JY,et al. Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza)[J]. ACTA PHARMACOLOGICA SINICA,2002,23(12):1163-1168. |
APA | Zhang, H.,Yu, C.,Jia, JY.,Leung, SWS.,Siow, YL.,...&Zhu, DY.(2002).Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza).ACTA PHARMACOLOGICA SINICA,23(12),1163-1168. |
MLA | Zhang, H,et al."Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza)".ACTA PHARMACOLOGICA SINICA 23.12(2002):1163-1168. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论